Profil
Ho-Young Ban is the founder of Neofect Co., Ltd. since 2010, holding the title of Chief Executive Officer & Director.
Mr. Ban's current jobs include Chief Financial Officer, Secretary & Director at Neofect USA, Inc. and Venture Partner at Digital Healthcare Partners Co., Ltd. Education history includes an undergraduate degree from Korea Advanced Institute of Science & Technology and an MBA from the University of Virginia Darden School of Business.
Postes actifs de Ho-Young Ban
| Sociétés | Poste | Début |
|---|---|---|
| DYNAMIC SOLUTION CO.,LTD. | Fondateur | 04/06/2010 |
Neofect USA, Inc.
Neofect USA, Inc. Internet RetailRetail Trade Operates direct selling establishments | Directeur Financier/CFO | - |
Digital Healthcare Partners, Inc.
Digital Healthcare Partners, Inc. Investment ManagersFinance DHP invests in companies located in South Korea. The firm targets companies operating in the healthcare sector. It participates in seed and early stage capital requirements. | Private Equity Investor | - |
Formation de Ho-Young Ban
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Korea Advanced Institute of Science & Technology
Korea Advanced Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Virginia Darden School of Business
University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neofect Co., Ltd.
Neofect Co., Ltd. Medical SpecialtiesHealth Technology Provides rehabilitation solutions | Health Technology |
Neofect USA, Inc.
Neofect USA, Inc. Internet RetailRetail Trade Operates direct selling establishments | Retail Trade |
Digital Healthcare Partners, Inc.
Digital Healthcare Partners, Inc. Investment ManagersFinance DHP invests in companies located in South Korea. The firm targets companies operating in the healthcare sector. It participates in seed and early stage capital requirements. | Finance |
















